A two-part dose-rising study to evaluate the safety, tolerability and pharmacokinetics of SB-751689 [ronacaleret] when administered as an oral formulation at supratherapeutic dose levels in healthy adult subjects.

Trial Profile

A two-part dose-rising study to evaluate the safety, tolerability and pharmacokinetics of SB-751689 [ronacaleret] when administered as an oral formulation at supratherapeutic dose levels in healthy adult subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Mar 2009

At a glance

  • Drugs Ketoconazole; Ronacaleret
  • Indications Postmenopausal osteoporosis
  • Focus Adverse reactions
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 18 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 10 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top